Different sleep pattern in over-weight/obese women with polycystic ovary syndrome

Context Sleep duration and sleep quality have important health implications although our knowledge of objectively measured sleep variables in women with Polycystic Ovary Syndrome (PCOS) is limited. Objective To compare sleep variables assessed by actigraphy in over-weight/obese women with PCOS and controls, and to assess sleep variables after behavioral modification intervention in comparison with minimal intervention in a randomized trial. Design Randomized controlled trial, and a control group. Setting Outpatient gynecological clinic at a university hospital in Sweden. Participants 39 women fulfilling all Rotterdam PCOS criteria, randomized to behavioral modification intervention or minimal intervention and 21 controls with no other metabolic disease, all aged 18‐40 years with a BMI ≥ 27 kg/m2. Intervention A four-month behavioral modification intervention including weekly group meetings focusing on behavioral and healthy lifestyle aspects. Minimal intervention reflecting standard care. Main outcome measure Sleep durations and sleep efficiency assessed by actigraphy. Results Compared to the control group, women with PCOS had significantly shorter time in bed (501 vs 548 min, p= 0.049), sleep time over 24 hours (448 vs 567 min, p=0.005) and sleep time at night (434 vs 511 min, p=0.002), poorer sleep efficiency (87 vs 93%, p<0.001), and longer wakefulness after sleep onset (64 vs 38 min, p<0.001). However, total sleep time at night for women with PCOS (7.2hrs) was within the normal range. Following behavioral modification intervention, the reduction from baseline in sleep over 24 hours and in the daytime sleep were significant compared to the minimal intervention group (78 min, p=0.009 and 43 min, p=0.003 respectively). Conclusions We found over-weight/obese women with PCOS to have normal sleep duration, but worse sleep efficiency than controls. Behavioral modification intervention seems to reduce the amount of daytime sleep, suggesting improved sleep behavior. Clinical trials registration https://doi.org/10.1186/ISRCTN48947168, identifier ISRCTN48947168.

[1]  M. Naghizadeh,et al.  Sleep duration and anthropometric indices in an Iranian population: the Fasa PERSIAN cohort study , 2021, Scientific Reports.

[2]  Y. Yang,et al.  The mental health of Chinese women with polycystic ovary syndrome is related to sleep disorders, not disease status. , 2020, Journal of affective disorders.

[3]  R. Sarkis,et al.  Sleep assessment by means of a wrist actigraphy-based algorithm: agreement with polysomnography in an ambulatory study on older adults , 2020, Chronobiology international.

[4]  A. Hirschberg,et al.  Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial. , 2020, European journal of endocrinology.

[5]  M. Murad,et al.  Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta‐analysis , 2020, Clinical endocrinology.

[6]  M. Cree‐Green,et al.  Morning circadian misalignment is associated with insulin resistance in girls with obesity & Polycystic Ovarian Syndrome. , 2019, The Journal of clinical endocrinology and metabolism.

[7]  L. Moran,et al.  Sleep disturbances in women with and without polycystic ovary syndrome in an Australian National Cohort , 2019, Clinical endocrinology.

[8]  A. Hirschberg,et al.  Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention—A randomized controlled trial , 2019, Clinical endocrinology.

[9]  S. Tufik,et al.  Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism. , 2019, Revista da Associacao Medica Brasileira.

[10]  A. Coomarasamy,et al.  Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study , 2019, European journal of endocrinology.

[11]  K. Hidayat,et al.  Daytime napping and risk of type 2 diabetes: a meta-analysis of prospective studies , 2018, Sleep and Breathing.

[12]  L. Redman,et al.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome , 2018, Clinical endocrinology.

[13]  T. Åkerstedt,et al.  Sleep duration and mortality – Does weekend sleep matter? , 2018, Journal of sleep research.

[14]  H. Teede,et al.  Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. , 2018, Fertility and sterility.

[15]  Habibolah Khazaie,et al.  Sleep Architecture in Patients With Primary Snoring and Obstructive Sleep Apnea , 2018, Basic and clinical neuroscience.

[16]  S. Redline,et al.  Actigraphy-based sleep estimation in adolescents and adults: a comparison with polysomnography using two scoring algorithms , 2018, Nature and science of sleep.

[17]  M. Sammel,et al.  High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis , 2017, Human reproduction.

[18]  Andrew Krystal,et al.  National Sleep Foundation's sleep quality recommendations: first report☆ , 2017, Sleep health.

[19]  E. Karabulut,et al.  The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. , 2016, Human reproduction.

[20]  M. Kramer,et al.  Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional Study , 2016, PloS one.

[21]  P. Lichtenstein,et al.  Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort , 2016, Psychoneuroendocrinology.

[22]  P. Mittal,et al.  Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome. , 2016, Sleep medicine.

[23]  M. Olszanecka-Glinianowicz,et al.  Sleep disturbances in women with polycystic ovary syndrome , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[24]  Yong Zhao,et al.  Daytime napping and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. , 2015, Sleep medicine.

[25]  F. Labrie,et al.  A rapid and sensitive UPLC–MS/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3α, 17β diol 17-glucuronide in postmenopausal women , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  L. Moran,et al.  Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. , 2015, Human reproduction.

[27]  F. Labrie,et al.  A sensitive, simple and robust LC–MS/MS method for the simultaneous quantification of seven androgen- and estrogen-related steroids in postmenopausal serum , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  E. Stothard,et al.  Metabolic Consequences of Sleep and Circadian Disorders , 2014, Current Diabetes Reports.

[29]  Y. Cheong,et al.  Poor sleep in PCOS; is melatonin the culprit? , 2013, Human reproduction.

[30]  A. Tennant,et al.  Construct validity of the psychological general well being index (PGWBI) in a sample of patients undergoing treatment for stress-related exhaustion: a rasch analysis , 2013, Health and Quality of Life Outcomes.

[31]  E. Diamanti-Kandarakis,et al.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. , 2012, Endocrine reviews.

[32]  T. Reinehr,et al.  Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome , 2011, Journal of sleep research.

[33]  G. Beccuti,et al.  Sleep and obesity , 2011, Current opinion in clinical nutrition and metabolic care.

[34]  L. Moran,et al.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.

[35]  F. Cappuccio,et al.  Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. , 2010, Sleep.

[36]  C. Labrie,et al.  Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  C. Björkelund,et al.  Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. , 2005, Diabetes care.

[38]  A. Malhotra,et al.  Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[39]  E. Bixler,et al.  Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. , 2001, The Journal of clinical endocrinology and metabolism.

[40]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[41]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.